Product Description

🔹 Product Overview
DOXULIP 20 mg Injection is a anticancer medicine containing Doxorubicin Hydrochloride 20 mg, an anthracycline chemotherapy agent. It is used to treat a wide range of cancers, including breast cancer, ovarian cancer, leukemias, lymphomas, and certain soft tissue and bone sarcomas. The medicine is administered intravenously by a qualified healthcare professional as part of a chemotherapy regimen.

🔹 Key Uses
Treatment of breast cancer
Management of ovarian cancer
Treatment of Hodgkin lymphoma and Non-Hodgkin lymphoma
Treatment of acute leukemias
Management of soft tissue and bone sarcomas
Treatment of bladder, thyroid, stomach, and lung cancers
Used in selected pediatric cancers such as Wilms' tumor and neuroblastoma, when prescribed by an oncologist.

🔹 Composition
Active Ingredient: Doxorubicin Hydrochloride 20 mg
Drug Class: Anthracycline Antineoplastic (Chemotherapy Agent)
Dosage Form: Injection (Intravenous)

🔹 How It Works
DOXULIP 20 mg Injection contains Doxorubicin, which works by interfering with the DNA of rapidly dividing cancer cells. It inhibits the enzyme topoisomerase II and disrupts DNA replication, preventing cancer cells from growing and multiplying. This leads to the destruction of cancer cells while helping slow disease progression.

🔹 Key Benefits
Effective treatment for various solid tumors and blood cancers
Helps slow or stop the growth of cancer cells
Can be used alone or in combination with other chemotherapy medicines
Widely used in established oncology treatment protocols
Administered under specialist medical supervision for optimal safety

🔹 Dosage and Administration
Use only as prescribed by an oncologist.
Administered intravenously by a trained healthcare professional.
Dosage depends on the type of cancer, body surface area, age, and overall health.
Do not self-administer.
Regular blood tests and heart function monitoring may be required during treatment.

🔹 Possible Side Effects
Like all chemotherapy medicines, DOXULIP 20 mg Injection may cause side effects.
Common side effects include:
Nausea and vomiting
Hair loss
Mouth sores
Loss of appetite
Fatigue
Diarrhea
Low white blood cell count
Injection site reactions
Temporary reddish discoloration of urine for 1–2 days after treatment
Seek immediate medical attention if you experience fever, signs of infection, chest pain, difficulty breathing, severe allergic reactions, or unusual bleeding.

🔹 Precautions
Use only under the supervision of a qualified oncologist.
Inform your doctor if you have heart disease, liver disease, kidney disease, or previous chemotherapy treatment.
Regular monitoring of blood counts, liver function, and heart function is recommended.
Avoid pregnancy during treatment and use effective contraception if advised.
Breastfeeding is generally not recommended during therapy.
Inform your healthcare provider about all medicines and supplements you are taking.